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Abstract
Background: Periventricular leukomalacia (PVL) is a frequent complication of preterm delivery.
Proinflammatory cytokines, such as interferon-γ (IFN-γ) and tumor necrosis factor α (TNF-α)
released from astrocytes and microglia activated by infection or ischemia have previously been
shown to impair survival and maturation of oligodendrocyte progenitors and could thus be
considered as potential factors contributing to the generation of this disease. The first goal of the
present study was to investigate whether exposure of oligodendrocyte precursors to these
cytokines arrests the maturation of ion currents in parallel to its effects on myelin proteins and
morphological maturation. Secondly, in the search for agents, that can protect differentiating
oligodendrocyte precursor cells from cytokine-induced damage we investigated effects of
coapplications of corticosteroids with proinflammatory cytokines on the subsequent survival and
differentiation of oligodendrocyte progenitor cells.
Methods: To exclude influences from factors released from other cell types purified cultures of
oligodendrocyte precursors were exposed to cytokines and/or steroids and allowed to
differentiate for further 6 days in culture. Changes in membrane surface were investigated with
capacitance recordings and Scanning Ion Conductance Microscopy. Na+- and K+- currents were
investigated using whole cell patch clamp recordings. The expression of myelin specific proteins
was investigated using western blots and the precursor cells were identified using immunostaining
with A2B5 antibodies.
Results: Surviving IFN-γ and TNF-α treated cells continued to maintain voltage-activated Na+- and
K+  currents characteristic for the immature cells after 6 days in differentiation medium.
Corticosterone, dihydrocorticosterone and, most prominently dexamethasone, counteracted the
deleterious effects of IFN-γ and TNF-α on cell survival, A2B5-immunostaining and expression of
myelin basic protein. The most potent corticosteroid tested, dexamethasone, was shown to
counteract cytokine effects on membrane surface extension and capacitance. Furthermore,
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coapplication of dexamethasone blocked the cytokine-induced downregulation of the inwardly
rectifying potassium current in 80% of the precursor cells and restored the cytokine-blocked
down-regulation of the voltage activated Na+- and K+ currents during subsequent differentiation.
Conclusion:  Our results show that treatment of oligodendrocyte precursors with the
inflammatory cytokines TNF-α and IFN-γ block the differentiation of oligodendrocyte precursors
at the level of the differentiation of the voltage-gated ion currents. Co-treatment with
corticosteroids at the time of cytokine application restores to a considerable extent survival and
differentiation of oligodendrocytes at the level of morphological, myelin protein as well as ion
current maturation suggesting the option for a functional restoration of cytokine-damaged
immature oligodendrocytes.
Background
Perinatal brain injury is frequently associated with periv-
entricular leukomalacia (PVL), a condition characterised
by disrupted myelination due to loss of oligodendrocyte
progenitors [1]. In addition to hypoxic-ischemic brain
damage an increased incidence of PVL in very premature
fetuses has recently been related to immune responses in
the brain [2-5]. For instance, in autopsies of children with
PVL increased numbers of reactive interferon-γ (INF-γ)
positive astrocytes have been found [6]. Studies per-
formed in cell cultures from postnatal rat brain have
shown that the inflammatory cytokines tumor necrosis
factor-α (TNF-α) and IFN-γ not only induce apoptotic cell
death but additionally prevent the morphological differ-
entiation of oligodendrocyte progenitors as well as the
expression of myelin-specific proteins [7-11] confirming
the possible involvement of these factors in the genera-
tion of PVL.
In addition to expressing characteristic myelin proteins,
such as myelin basic protein (MBP), myelin-associated
glycoprotein (MAG) and 2',3' cyclic nucleotide 3'phos-
phodiesterase (CNP), mature oligodendrocytes differ in
their pattern of ion channel expression from precursor
cells. Whereas precursor cells express, among others, volt-
age-activated sodium and delayed K+ currents these cur-
rent types are down-regulated in the course of
differentiation [12,13]. In differentiated oligodendrocytes
the predominant current is an inwardly rectifying K+-cur-
rent [14]. The outward rectifier K+-current, prominent in
A2B5 progenitor cells, has been implicated in glial cell
proliferation [15-18]. The inward rectifier is regarded as
the prominent current involved in the removal of extracel-
lular K+ released out of active neurons and serves to main-
tain the negative resting membrane potential. By limiting
extracellular K+  activity transients it is responsible for
some of the physiological functions of the mature cell (see
e.g. [19]). It is so far unknown, whether the maturation
block by TNF-α and IFN-γ affects the developmental
down-regulation of voltage-activated ion channels as well.
Additionally, a first step in the search for a potential treat-
ment of PVL would be to find factors that prevent the
damaging effects of cytokines on the survival and differen-
tiation of oligodendrocyte progenitor cells. Corticoster-
oids have been reported to exert beneficial effects in
demyelinating diseases that are associated with the release
of various cytokines. For instance, in acute flare-ups of
multiple sclerosis, glucocorticoid treatment may reduce
the severity of symptoms and speed up the recovery
[20,21]. In fact, application of corticosteroids has been
shown to protect mature oligodendrocytes from apopto-
sis induced by TNF-α and IFN-γ [22]. Since in PVL pre-
dominantly oligodendrocyte precursors are damaged we
now extended these investigations by analyzing whether
corticosteroids exert a protective effect on survival, protein
expression, morphological and ion current maturation in
cytokine-treated oligodendrocyte progenitor cells. In a
preceding investigation on purified oligodendrocyte pro-
genitors we had observed in accordance with [9] and [22],
that a combination TNF-α and IFN-γ is far more potent in
inducing apoptosis than either factor in separation. In the
present study we thus used the cytokine concentrations
previously shown to result in a survival of about 10% of
the cells, containing about 35% A2B5 positive cells fol-
lowing six days of differentiation in culture [10].
Methods
Cell culture
Primary cultures of mixed glial cells were prepared from
brains of 1–3-day-old Sprague-Dawley rats according to
procedures described previously [23]. After decapitation
the brains were transferred to a culture dish containing
PBS (phosphate buffered saline: 138 mM NaCl, 8.1 mM
Na2HPO4, 2.7 mM KCl, 1.47 mM KH2PO4), freed of the
meninges, and mechanically disrupted by passing
through a 125 μm and a 36 μm nylon mesh, respectively.
After centrifugation of the cell suspension (10 min, 900
rpm at 4°C) the cell pellet was resuspended in DMEM/
HAM's F12 (1:1) supplemented with 10% heat-inacti-
vated fetal calf serum (FCS), 100 U/ml penicillin and 100
μg/ml streptomycin. Single cell suspensions were trans-
ferred to culture flasks (ca. 1.5 brains per 75-cm2 flask)Journal of Neuroinflammation 2008, 5:39 http://www.jneuroinflammation.com/content/5/1/39
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and preincubated at 37°C in a humidified atmosphere of
air/5% CO2. The medium was changed first after three
days in vitro and on alternate days thereafter.
After a pre-culture period for 8–11 days the cellular debris
and microglia growing loosely on top of the mixed glia
monolayer were removed by shaking the culture flasks for
3 h at 190 rpm. After discarding the supernatant the mon-
olayer was washed once with phosphate buffered saline,
and fresh medium was added. The phase dark cells (repre-
senting oligodendrocyte progenitors) growing on the
astrocyte layer were separated by prolonged shaking at
190 rpm for 16–18 h.
The suspension was collected and centrifuged for 5 min at
1700 rpm. The pellet was resuspended (3 ml per brain)
and preplated onto 10 cm2  plastic dishes, to which
endothelial cells, microglia and fibroblasts attached, that
had been removed by the shaking procedure in addition
to the oligodendrocyte precursors. After 45 min the non-
adherent cells were replated onto glass coverslips coated
with 0.25 mg/ml poly-D-lysin (105 cells per coverslip).
After 1 h the medium was changed to proliferation
medium (neurobasal medium (NB) + B27-supplement
without antioxidants (both from Life Technologies
GmbH, Karlsruhe, Germany) + 10 ng/ml PDGF + 10 ng/
ml bFGF (both from R&D Systems, Wiesbaden, Ger-
many)). More than 90% of the cells in culture were oli-
godendrocyte progenitors, as assessed by
immunostaining for A2B5. Three days after plating the
cells were transferred into differentiation medium (NB +
B27-supplement without antioxidants + 10 ng/ml ciliary
neurotrophic factor (CNTF) + 5 μm forskolin + 45 nM tri-
iodo-L-thyronine (T3)) [24] and cultured under these
conditions with a complete medium change every two
days.
At 24 h after seeding parts of the cultures were treated with
cytokines (recombinant rat IFN-γ (10 U/ml) and TNF-α
(10 ng/ml), both R&D Systems, Wiesbaden, Germany)
and/or corticosteroids (corticosterone (CS), deoxycorti-
costerone (DC) and dexamethasone (D), 1 μM each,
Sigma Aldrich GmbH, Taufkirchen, Germany). After 48
hours treatment was terminated by transferring cells into
differentiation medium containing no cytokines and/or
corticosteroids. Cells of the control groups were kept
under identical experimental conditions except for the
application of cytokines and/or corticosteroids. Experi-
ments were performed at day 6 after transfer into the dif-
ferentiaton medium.
Immunocytochemistry
The antibody used to characterise oligodendrocyte pro-
genitors was the monoclonal anti-A2B5 antibody
(MAB312R from Chemicon International, Hofheim, Ger-
many). At day 9 after seeding cells growing on 12 mm cov-
erslips were washed three times in phosphate buffered
solution (PBS), fixed for 20 min in 4% paraformaldehyde
in PBS and washed again three times in PBS.
Nonspecific sites were blocked in PBS containing 3% goat
serum and 0.1% BSA. Then cells were exposed to the anti-
body solution, 1:200 in PBS/1% goat serum (Sigma
Aldrich GmbH, Taufkirchen, Germany) for 1 h at room
temperature. After exposure to the primary antibody, cells
were washed three times with PBS and then incubated for
1 h in Alexa Fluor 488 goat anti-mouse IgM (1:1000 in
corresponding buffer/1% goat serum; Molecular Probes
Europe, Leiden, Netherlands). Finally cells were washed
three times in PBS and the coverslips were mounted on
glass microscope slides using Immuno-Fluore™ (ICN Bio-
medicals GmbH, Eschwege, Germany).
To assess total cell count as well as the percentage of A2B5-
positive cells under various culture conditions average cell
counts of 25 fields of view from each coverslip were eval-
uated with a 40× objective using a Zeiss Axioplan micro-
scope. The total cell number was determined by counting
process-bearing cells using phase contrast optics.
Determination of cell volume and membrane surface
Cell surface and volume measurements were performed
by scanning ion conductance microscopy [25,26] in the
back-step mode [27,28]. Glass capillaries (thin walled GB
150-TF 8P, Science Products) where pulled in a two step
process to a resistance of 6–8 MΩ when filled with bath
solution, corresponding to an opening diameter of
approximately 0.5–1 μm. The thin walled glass reduces
both the mass of the electrode as well as unintended con-
tacts between electrode and cell membrane at regions of
the scanned cells where the slope is high. The large open-
ing diameter additionally ensures an early detection of the
approach of the capillary to the cell surface and is thus
well suited for fast scans. The scanned area was 30 × 30
μm with a lateral step size of 1 μm and a vertical step size
of 50 nm. Backstep size was 7 μm. With this configuration
a typical scan of a cell surface took about 4 minutes,
allowing scanning of several cells per cover slip. Soma vol-
umes were calculated by summing the products of height
and base area (1 μm2) for each point in the xy-plane with
a height of at least 2 μm. Cell surfaces were determined as
described in [29].
Immunoblot analysis
At 9 days after plating cells were lysed in a buffer contain-
ing 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 40 mM NaF,
5 mM EDTA, 1 mM Na3VO4, 1% (v/v) nonidet P40, 0.1%
(w/v) sodium desoxycholate, 0.1% (w/v) sodium dodecyl
sulfate (SDS), 1 mM phenylmethylsulfonyl fluoride
(PMSF) and 10 μg/ml aprotinin. Protein concentrationsJournal of Neuroinflammation 2008, 5:39 http://www.jneuroinflammation.com/content/5/1/39
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in cell lysates were determined using the Bio-Rad protein
assay kit.
Protein samples (10 μg per lane) were separated by
sodium dodecyl sulfate (SDS)-polyacrylamide gel electro-
phoresis (PAGE) according to the method of Laemmli and
blotted onto a nitrocellulose membrane. For detection of
myelin basic protein (MBP), 2',3' cyclic nucleotide
3'phosphodiesterase (CNP) and actin we used a 12% gel
under reducing conditions. Myelin-associated glycopro-
tein (MAG) was identified by means of a 8% gel under
non-reducing conditions. Then the membrane was
blocked with 5% skim milk powder in TBS (25 mM Tris-
HCl, 150 mM NaCl, pH 7.5) for 1 h and incubated with
suitably diluted primary antibodies for another hour
(MAG 1: 10; MAB1567 Chemicon International, Hof-
heim, Germany/CNP 1:40; MAB326R, Chemicon Interna-
tional, Hofheim, Germany/MBP 1:100; SM1450, DPC
Biermann, Bad Nauheim, Germany/actin 1:400; A2066,
Sigma Aldrich GmbH, Taufkirchen, Germany). After three
washes with TBST (TBS + Tween 20) the membrane was
incubated with anti-IgG-alkaline phosphatase conjugate.
The blots were finally visualized using ECL detection rea-
gents (Amersham Biosciences Europe GmbH, Freiburg,
Germany). Band intensities were analyzed by TINA 2.09
software and normalized to actin.
All experiments were performed at least three times. The
numbers of coverslips analysed for each experimental
condition are given in the respective figure legends. Values
are given as means ± SE.
Electrical recordings
Electrical recordings were performed in the whole cell
configuration of the patch clamp technique. Prior to
recording coverslips were transferred to a 3.5 cm diameter
plastic Petri culture dish containing an extracellular
recording solution (ExGlu) of the following composition
(in mM): 110 NaCl, 5.4 KCl, 1.8 CaCl2, 0.8 MgCl2, 10
HEPES, 10 Glucose. The osmolarity was the same as that
of the culture medium, 250 mOsm, the pH was adjusted
to 7.3. Electrodes were pulled with a two-step puller (Nar-
ishige PP-830) from borosilicate glass tubing with fila-
ment (GB 150-TF 8P, Science Products, Hofheim) and
filled with a solution containing (in mM): 100 K-gluco-
nate, 0.1 CaCl2, 1.1 EGTA, 5 MgCl2, 10 HEPES, 3 ATP. The
pH of this solution was adjusted to 7.3, the osmolarity
was 235 mOsm. A liquid junction potential of this solu-
tion with respect to the bath solution of 15 mV was cor-
rected offline. The typical resistance of recording
electrodes containing this filling solution amounted to 4–
5 MΩ. Recording electrodes were positioned via a 3-axis
micromanipulator (M-105, Physics Instruments), which
was mounted on a Zeiss IM-35 inverted microscope. Fine
positioning of the electrode was controlled with a piezo
actuator (DC-Mike M-232, Physics Instruments). The elec-
trodes were connected to the headstage of an EPC7 volt-
age clamp amplifier (List Medical, Darmstadt, Germany).
The generation of voltage protocols and the digital acqui-
sition of currents were performed using PClamp 6 soft-
ware and a Digitata 1200B AD/DA system (both Axon
Instruments). Signals were filtered using the EPC7 10 kHz
lowpass filter and then digitized with a sampling rate of
25 kHz. Series resistance errors were minimized by dis-
carding recordings with access resistances of more than 20
MΩ. The formation of a high resistance seal (greater than
2 GΩ in most cases) and rupture of the membrane were
monitored using small hyperpolarizing voltage pulses
between 1 and 50 mV.
Na+-currents were monitored by a series of test pulses
incrementing in 5 mV steps starting from a holding poten-
tial of -85 mV. Leakage and capacitive artifacts were sub-
tracted using a P/4 protocol. Na+-current densities were
determined from the peak Na+-current at a test potential
of -20 mV normalized to the membrane capacitance cal-
culated from the integral of the charging curve for a test
potential step of 20 mV after compensation of the elec-
trode capacitance. Voltage-activated K+-currents (Kv) were
determined from the average values recorded in the inter-
val between 50–60 ms after onset of a test pulse +25 mV.
To eliminate the effect of contaminating inward rectifier
K+-currents all Na+- and Kv- currrents were measured in a
solution containing 1 mM Ba2+. This treatment had no
effect on the amplitudes of the Na+ currents but reduced
the outward currents by 47 ± 6% (n = 15) in cells after two
days of cytokine treatment and by 49 ± 8% (n = 9) in con-
trol cells after 3 days in proliferation medium, corre-
sponding a partial block of outward K+ currents by Ba2+
[30].
Inwardly rectifying K+  currents (KIR) were determined
applying a test pulse protocol consisting of a series of test
pulses from -175 mV to +20 mV in the absence of auto-
matic leakage and capacitive current subtraction. KIR cur-
rents were determined as the Ba2+-blockabale part of the
current by applying the same voltage protocol in ExGlu
solution first followed by a switch to ExGlu solution sup-
plemented by 1 mM BaCl2, and subtracting the recorded
traces for each voltage step. The current density was deter-
mined from the difference trace at a test voltage of -135
mV normalized to the cell capacitance calculated from the
integral of the charging curve. A cell was regarded as
expressing a KIR current when the current exceeded 50 pA.
A simple gravity controlled perfusion system was used to
apply either ExGlu or KIR-blocking solution through a
multibarrel pipette. The perfusion was adjusted initially
by monitoring the flow of an ink solution to asssure a
complete solution exchange after switching between the
two supplies. The liquid level was controlled via an adjust-Journal of Neuroinflammation 2008, 5:39 http://www.jneuroinflammation.com/content/5/1/39
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able suction needle, connected to a reversed "Optimal"
aquarium pump (Schego, Offenbach, Germany). Cells for
surface scanning or electrical recording were selected
under phase contrast optics. On day 3 in culture, irrespec-
tive of treatment conditions, most cells showed a bipolar
morphology and these were selected for recording. One
aim of this investigation was to find out, whether cells
retaining the bipolar morphology and A2B5 positivity
after cytokine treatment followed by 6 days in differentia-
tion medium also maintain the immature ion current pat-
tern or whether voltage-activated cation currents are
down-regulated by the incubation in differentiation
medium irrespective of the maintenance of the immature
morphology of the cells. To this aim recordings on day 9
after seeding in cultures treated with cytokines only were
performed on bipolar cells. To test, whether morphologi-
cally differentiated cells show a downregulation of volt-
age-activated Na+  and K+  currents, as expected during
normal differentiation of oligodendrocytes, multipolar
cells were investigated on day 9 in the three other popula-
tions showing more than 90% multipolar cells staining
negative for A2B5.
The statistical significance of differences between groups
was assessed by ANOVA followed by Tuckey's Post-hoc
Test. All data represent mean value ± SE.
Results
The effect of a transient treatment of progenitor cells with
cytokines and the effect of a coapplication of corticoster-
oids on the subsequent differentiation into mature oli-
godendrocytes were studied using the culture protocol
depicted in Figure 1G. Total cell numbers, percentages of
A2B5 immunopositive cells, soma and process volumes
and surface areas, membrane capacitances, the expression
of myelin specific proteins and voltage activated Na+, K+ as
well as inwardly rectifying K+ currents were evaluated fol-
lowing six days of differentiation in culture.
Corticosteroids attenuate cytokine induced cell death and 
decrease the percentage of A2B5-positive cells
To extend previous qualitative observations suggesting
that corticosteroid treatment counteracts apoptosis and
arrest of maturation [31] isolated progenitors were treated
for 3 days in proliferation medium, transferred into differ-
entiation medium and investigated six days later (Figure
1G). We had previously shown that incubation with IFN-
γ and TNF-α caused a dramatic loss in numbers of surviv-
ing cells as compared with controls [10]. We now repeated
these experiments in the presence of glucocorticoids. After
co-application of cytokines and glucocorticoids the
number of surviving cells per field amounted to 32.7 ± 4.9
(DC, deoxycorticosterone), 47.1 ± 5.4 (CS, corticoster-
one) and 72.5 ± 7.4 (D, dexamethasone, 25 fields of view
on 4 coverslips counted for each condition) which was
significantly higher than the 13.7 ± 1.9 cells previously
found to survive in control cultures. Control cultures
treated with corticosteroids in the absence of cytokines
showed a slight 0.4-fold increase in the total cell number
(188.3 ± 4.6 (CS), 175.7 ± 5.6 (DC) and 187.4 ± 7.6 (D),
vs. 135.0 ± 5.8 n = 12, Figure 1E) compared with the pre-
viously observed number of 135 ± 5.8 for control cultures
[10].
We had previously observed, that in differentiating con-
trol cultures the percentage of A2B5 positive cells declined
after 6 days in differentiation medium to 1.0% and the
cells developed the characteristic arborisation of mature
oligodendrocytes (see e.g. Figure 2A). Likewise, we now
observed that this fraction is comparable after treatment
of control cultures with one of the three corticosteroids
yielding a similar reduction of A2B5-positive cells,
amounting to 2.5 ± 0.8% (CS), 2.3 ± 0.5% (DC), 1.8 ±
0.5% (D), n = 3 coverslips evaluated for each corticoster-
oid (Figure 1F). In contrast to this down-regulation of
A2B5 positive cells we had observed that 36% of the IFN-
γ/TNF-α-treated surviving cells still stained positive for
A2B5 (Figure 1C, F) after six days in differentiation
medium and the cells maintained a bipolar morphology
(Figure 1C, Figure 2C) as compared with the extensive
arborizations developed by the differentiated control cells
(Figure. 1A, 2A). Remarkably, we now observed that the
cytokine-induced preservation of the A2B5 phenotype
was almost completely reversed by coapplication of corti-
costeroids. While after cytokine treatment 36.3 ± 3.9% (n
= 9) of the cells had maintained the A2B5 antigen expres-
sion [10] the percentage of A2B5-positive cells reversed to
values found in control cultures after cotreatment with
corticosteroids (1.5 ± 0.1% (IFN-γ + TNF-α + CS); 7.4 ±
1.4% (IFN-γ + TNF-α + DC); 1.6 ± 0.4% (IFN-γ + TNF-α +
D, Figure 1F, n = 3 coverslips evaluated for every corticos-
teroid).
Restoration of membrane growth during differentiation of 
dexamethasone protected cells
Cytokine and corticosteroid effects on the surface mem-
brane extension of the cells were investigated using Scan-
ning Ion Conductance Microscopy (SICM) and
capacitance measurements in the whole cell configuration
of the patch-clamp technique. Differentiated control cells
showed an average membrane capacity of 89 ± 9 pF (n =
16), a soma volume of 1107 ± 81 fL (n = 10), an average
soma surface of 539 ± 72 μm2 (n = 8) as well as an average
cell surface of 1793 ± 180 μm2 (n = 8) in the scanning
frame of 30 μm × 30 μm.
Cytokine treated cells showed, however, significantly
smaller membrane capacitances than control cells (20 ± 1
pF, n = 29; p < 0.001) indicating 4.5 times less membrane
surface per cell (Figure 2F). This was further confirmedJournal of Neuroinflammation 2008, 5:39 http://www.jneuroinflammation.com/content/5/1/39
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with SICM-measurements showing significantly smaller
soma volumes of 572 ± 60 fL, (n = 8, p < 0.05) compared
with control cells (Figure 2E). The soma surfaces were 339
± 19 μm2 (n = 9, p = 0.047) and reduced to a smaller
extend (a factor of 1.6) than the whole cell surfaces (806
± 52 μm2, n = 9, p < 0.001), which were reduced by a fac-
tor of 2.2 (Figure 2G and 2H). The smaller reduction of
the soma surface compared with the cell surface quantita-
tively confirms the intuitive impression that the cytokine
treated, more immature cells produce a smaller myelin
generating membrane surface (Figure 2C).
Cytokine-treated cells were then cotreated with dexameth-
asone, the steroid that had shown the most potent effect
on cell survival (Figure 1E). Dexamethasone-treatment
had no effect on cell capacitances, surface areas and vol-
umes of control cells (Figure 2B, E–H). However, co-treat-
ment of cytokine-exposed cells with dexamethasone led
to significantly larger cell sizes (Figure 2D). Hence,
cotreatment with dexamethasone increased the average
soma volume by a factor of 1.4 to 800 ± 72 fL (n = 11, Fig-
ure 2E). Whereas the average soma area was only insignif-
icantly larger (395 ± 21 μm2, n = 10) than the soma area
of the cytokine-treated cells (339 ± 19 μm2, n = 9) after
dexamethasone cotreatment, this treatment led to a signif-
icant increase of the area of the cell processes by a factor
of 1.9 to 1495 ± 202 μm2 (n = 7, p < 0.01, Figure 2G and
2H). This finding is further supported by an even larger
increase of the membrane capacitance from 20 ± 1 pF (n
= 29) to 70 ± 10 pF (n = 15; Figure 2F).
Cytokine-induced decreases in protein levels of MAG, 
MBP and CNP are attenuated by glucocorticoids
We next tested the glucocorticoid effects on characteristic
proteins involved in myelination. Similar to the morpho-
logical parameters the levels of MAG, MBP and CNP pro-
teins were not influenced by the glucocorticoids tested
(Figure 3). In accordance with previous observations
[10,31] protein levels of MBP, MAG, and CNP were, how-
ever, significantly reduced by cytokines from 17.7 ± 3.5%,
18.4 ± 2.8% and 14.4 ± 3.5% to 0.7 ± 0.3%, 0.9 ± 0.5%
and 4.1 ± 1.4% (Figure 3, n = 6 coverslips for MBP & CNP,
n = 3 coverslips for MAG). Coapplication of corticoster-
one and dexamethasone significantly reversed the
decrease in protein expression of MBP to 5.5 ± 1.3% and
9.8 ± 1.2% (Figure 3, n = 6 coverslips for each condition).
A non significant tendency for an increased expression of
CNP and MAG was additionally observed (Figure 3), sug-
gesting that the restoration of the expression of myelin
proteins by dexamethasone may be extended to further
membrane proteins.
Cytokine and dexamethasone action on voltage-activated 
sodium currents
In accordance with previous publications reporting volt-
age-activated Na+ currents in oligodendrocyte precursor
cells 70% of the bipolar cells investigated after 3 days in
proliferation medium showed voltage-activated sodium
currents of more than 50 pA (Figure 4C, d3C), displaying
an average Na+-current density of 12.8 ± 1.5 pA/pF (n =
34, mean ± SE, Figure 4D). In control cultures treated with
dexamethasone we observed Na+ currents larger than 50
pA in a slightly larger population of 75% of the cells
showing a slightly larger current density of 14.0 ± 1.7 pA/
survival and A2B5 staining of oligodendrocytes following treatments with cytokines and corticosteroids Figure 1 (see previous page)
survival and A2B5 staining of oligodendrocytes following treatments with cytokines and corticosteroids. Phase 
contrast microphotographs as well as anti-A2B5 staining after three days in proliferation medium followed by 6 days in differ-
entiation medium. Note, that after treatment of oligodendrocyte precursors with TNFα (10 ng/ml) and IFNγ (10 U/ml) for 48 
h on 2–3 days in vitro (C) cells display mostly bipolar morphologies typical for progenitor cells, maintaining their A2B5 immuno-
positivity. Coapplication of dexamethasone during cytokine treatment (D) in the proliferation medium restored the extension 
of multipolar arborizations and the downregulation of A2B5 staining. (E) Average number of cells per field of view at culture 
day 9 (for every bar 25 fields of view from 12 coverslips of the control cultures and 4 coverslips of the corticosteroid treated 
cultures were counted). In both, control (left bars) and in cytokine-treated cells (right bars) corticosteroids caused a significant 
increase in the total number of cells surviving in culture. (F) Percentage of A2B5 positive cells at culture day 9. Note, that in 
control cells not treated with cytokines (left four bars) no significant effect of corticosteroids on the number of A2B5-positive 
cells was detected, whereas in cytokine-treated cultures the percentage of A2B5-positive cells was decreased by cotreatment 
with corticosteroids (CS: corticosterone, DC: deoxycorticosterone, D: dexamethasone, no corticosteroid treatment (-) * p < 
0.05, ** p < 0.01, *** p < 0.001. For reasons of comparison the black bars in E and F are based on data published in [10], Figure 
3B. Since cell counting was performed directly at the fluorescence microscope, fields of view were slightly larger than the pho-
tomicrographic frames shown. (G) Flow chart of the experimental design: After day 1 in proliferation medium, test cultures of 
oligodendrocyte precursors were treated for 48 hours with control proliferation medium or 10 U/ml IFN-γ and 10 ng/ml TNF-
α in the presence or absence of glucocorticoids. The treatment was stopped by transferring the cells into differentiation 
medium. To judge long-term effects of treatments of precursor cells on subsequent differentiation most investigations were 
performed following 6 days in differentiation medium.Journal of Neuroinflammation 2008, 5:39 http://www.jneuroinflammation.com/content/5/1/39
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pF (n = 34). Oligodendrocyte precursor cell cultures
treated for two days with IFN-γ + TNF-α showed a reduced
percentage of 58% of cells expressing Na+-currents with
insignificantly reduced (p > 0.05) amplitudes of 8.8 ± 0.8
pA/pF (n = 30, Figure 4C, D d3TI). Again, cotreatment
with dexamethasone led to a slight increase in the number
of cells expressing Na+ currents to 66% showing a slight,
but insignificantly increased Na+ current amplitude of 9.2
± 1.0 pA/pF (n = 37, Figure 4C, D d3TID). Following fur-
ther six days in differentiation medium the cells had
changed their morphological appearance to multipolar
cells. In none of the 12 cells from control cultures investi-
gated a voltage-activated Na+ current was found (Figure
4C, d9C). Likewise, in the dexamthasone-treated control
cultures only one cell out of 13 cells investigated showed
a Na+-current. In contrast, 77% of the cytokine treated
cells that had been cultured in differentiation medium for
6 days and which had maintained a bipolar morphology
still showed voltage – activated Na+ currents with an aver-
age amplitude of 8.6 ± 1.5 pA/pF (n = 21, Figure 4C and
4D, d9TI). To investigate whether dexamethasone affects
the arrest of sodium current downregulation by TNF-α
and INF-γ, Na+-currents were studied in cytokine and dex-
amethasone co-treated cells followed by further differen-
tiation for 6 days. As depicted in Figure 4C, D following
co-treatment with cytokines and dexamethasone none of
the 11 cells investigated continued to show voltage-gated
Na+-currents (Figure 4C – d9TID).
Hence, in addition to preventing morphological matura-
tion treatment with TNF-α and INF-γ also prevents the
downregulation of voltage-activated sodium currents that
occurs during normal maturation of oligodendrocytes.
This effect can be reversed by cotreatment with dexameth-
asone.
Cytokine and dexamethasone effects on voltage activated 
potassium currents
During maturation of oligodendrocytes voltage-activated
K+-currents have been shown to be down-regulated in par-
allel with voltage-activated Na+-currents. In the following
we thus investigated whether cytokine treatment and co-
treatment with dexamethasone affects K+-currents as well.
All precursor cells maintained for three days in prolifera-
tion medium showed delayed K+-outward currents aver-
aging 25.5 ± 2.2 pA/pF (n = 48, Figure 5C, d3C),
consistent with previous reports on oligodendrocyte pre-
cursor cells in PDGF-containing medium [16]. Following
addition of dexamethasone for two days to control prolif-
eration medium insignificantly smaller K+ currents of 23.2
± 2.1 pA/pF (n = 46) were observed. In oligodendrocyte
precursor cells treated for three days with IFN-γ + TNF-α
the average amplitudes of the voltage-activated K+ currents
were significantly reduced to 17.5 ± 0.4 pA/pF (n = 47, Fig-
ure 5C, d3TI). Again, the coincubation with dexametha-
sone had only a slight effect and resulted in outward K+
current amplitudes of 16.2 ± 1.4 pA/pF (n = 50).
As expected for the differentiation of oligodendrocytes
after 6 days in differentation medium control cells show-
ing multiple arborizations only showed small residual
delayed K+ currents of 1.4 ± 0.3 pA/pF (n = 16, Figure 5C
– d9C). Likewise, current densities in dexamethasone-
treated control cells were reduced by a similar extent (Fig-
ure 5C d9CD).
However, bipolar cells maintained for 6 days in differen-
tiation medium after cytokine treatment continued to
express delayed rectifier K+ currents of on the average 14.5
± 1.8 pA/pF (n = 29, Figure 5C, d9TI), which is in accord-
ance with the maintenance of the undifferentiated pheno-
type, as well as the Na+ current expression of these cells.
Following co-treatment of the proliferating precursor cells
with cytokines and dexamethasone the delayed rectifyer
Morphological differences of cells cultured for 6 days in differentiation medium after various treatments visualized by Scanning  Ion Conductance Microscopy (SICM) Figure 2 (see previous page)
Morphological differences of cells cultured for 6 days in differentiation medium after various treatments visual-
ized by Scanning Ion Conductance Microscopy (SICM). (A) Samples of control oligodendrocytes pretreated with pro-
liferation medium alone, (B) proliferation medium supplemented with dexamethasone, (C) proliferation medium supplemented 
with IFN-γ and TNF-α, (D) proliferation medium supplemented with IFN-γ, TNF-α and dexamethasone. Scans were performed 
in a frame of 30 × 30 μm with 1 μm lateral step size. Calibration bar converting height into greyscale is shown at the right. (E) 
Average volume measurements of cell somata (height > 3 μm), calculated from the SICM-data. Note, that the smallest volumes 
correspond to cells pretreated with TNF-α and IFN-γ only and the reversal by cotreatment with dexamethasone. (F) Capaci-
tances of cells cultured under the same conditions as cells shown in A-D analysed using the whole cell voltage clamp technique. 
(G) Surface of cell processes with a height of more than 0.5 μm above the culture dish, calculated from the SICM data. (H) 
Soma surface (height of more than 3.0 μm above the culture dish) calculated from the SICM data. Note, that the TNF-α and 
IFN-γ treatment and dexamethasone rescue affect predominantly the process surface. Hence most of the capacitance is con-
tributed by the process membrane. Error bars indicate mean ± SE, * p < 0.05, ** p < 0.01, *** p < 0.001. C: control, DC: treat-
ment with dexamethasone, TI: treatment with TNF-α and IFN-γ, TID: cotreatment with TNF-α and IFN-γ plus dexamethasone 
each for two days in proliferation mediumJournal of Neuroinflammation 2008, 5:39 http://www.jneuroinflammation.com/content/5/1/39
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K+ current density was reduced on the average to the level
found in differentiated cells (2.4 ± 0.5 pA/pF, n = 15 – Fig-
ure 5C- d9TID). In accordance with our findings concern-
ing sodium currents, these observations suggest, that
cytokine pre- treatment prevents normal differentiation of
potassium outward currents and that the cytokine effects
can be prevented by co-treatment with dexamethasone.
Inwardly rectifying K+ currents
After three days in proliferation medium 70% of the con-
trol cells investigated showed an inwardly rectifying K+
current exceeding 50 pA (mean value 12.3 ± 2.1 nA/pF –
Figure 6C, D – d3C). Most of the inwardly rectifying K+
currents showed an inactivation at negative membrane
potentials reflected in the negative slope of the I/V rela-
tionship (Figure 6Aa, B). We did not further examine
whether this inactivation was voltage-dependent [32] or
due to the presence of Na+ in the recording solution [30].
However, we only observed the inactivation in about 60%
of the cells recorded from using identical solutions and
voltage protocols, suggesting an inhomogeneous expres-
sion pattern in the oligodendrocytes. Following treatment
with dexamethasone a similar fraction of 72% of the cells
recorded from showed inwardly rectifying K+-currents,
with an insignificantly reduced current density of 7.9 ± 0.5
pA/pF (n = 20, Figure 6C, D – d3CD). Remarkably, in oli-
godendrocyte precursor cells treated for two days with
IFN-γ + TNF-α only 20% of the cells investigated showed
an inwardly rectifying K+ current exceeding 50 pA (Figure
6 – d3TI). The average current density of the 9 cells out of
45 cells recorded, that showed a current exceeding 50 pA
displayed a slightly, but insignificantly (p > 0.05) smaller
amplitude as recorded in the control cells (9.1 ± 2.1 pA/
pF). Most interestingly, co-treatment with dexamethasone
restored the percentage of cells expressing inwardly recti-
fying potassium currents to 72%, showing almost identi-
cal current densities as observed in only dexamethasone
treated control cultures (7.2 ± 0.7 pA/pF, n = 16).
Figure 3
Protein expression of MAG, MBP and CNP at culture day 9 Figure 3
Protein expression of MAG, MBP and CNP at culture 
day 9. Note the strong reductions of myelin protein expres-
sion normalized to actin in western-blots from cells preincu-
bated with IFN-γ and TNF-α (bars to the right). Cotreatment 
with corticosterone (CS), deoxycorticosterone (DC) or 
dexamethasone (D), significantly attenuated the inhibition of 
protein expression for MBP (B) and showed a non-significant 
tendency for a recovery of CNP (C) and MAG (D), *p < 
0.05, ***p < 0.001. For reasons of comparison data shown in 
(B) are based on the same dataset as those shown in Figure 
2A of [31].Journal of Neuroinflammation 2008, 5:39 http://www.jneuroinflammation.com/content/5/1/39
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Following 6 days in differentation medium in control cul-
tures the inwardly rectifying K+ current was the dominant
current. While the absolute value of the KIR current, which
was expressed in 92% of the cells investigated had
increased from 169 ± 29 pA in the control percursor cells
to 864 ± 190 pA in the morphologically differentiated
cells the average current density, amounting to 10.3 ± 2.3
pA/pF (n = 25, Figure 6 – d9C) had only changed insignif-
icantly. Similarly, after 6 days in differentiation medium
81% of the cytokine-treated cells expressed inwardly recti-
fying K+ currents of an average density of 13.1 ± 2.7 pA/pF
(n = 27, Figure 6C, D – d9TI). Due to the smaller size of
the cells, the absolute current amplitudes (210.4 ± 40.6
pA/pF, n = 27) were only slightly larger than those of the
cytokine treated precursor cells at d3 (155.7 ± 35.7 pA/
pF). Remarkably, following 6 days after removal of
cytokine treatment and exposure to the differentiation
medium, KIR was recorded again in more than 80% of the
cytokine treated cells. This was slightly less than in the
dexamethasone pretreated and control differentiated cells
(Figure 6C, D – d9CD and d9TID), which expressed KIR in
100% of the cells recorded from.
Discussion
Cytokine effects on differentiation of oligodendrocyte 
precursors
Here we present the novel observations, that oligodendro-
cyte progenitors surviving inflammatory cytokine treat-
ment maintain the voltage – activated Na+- and K+-
currents characteristic of oligodendrocyte progenitors
[12,13,33]. Using a recently developed scanning ion con-
ductance microscope [29] we quantitatively determined
that the cytokine treatment impairs the extension of the
surface of the processes to a larger extent than the soma
surface. Hence, in accordance with the observed reduction
Figure 4
Voltage-activated sodium currents after three days in prolif- eration medium and further six days in differentiation  medium Figure 4
Voltage-activated sodium currents after three days 
in proliferation medium and further six days in differ-
entiation medium. (A) Original current traces from cell 
cultured for three days under control conditions recorded in 
Ba2+ containing extracellular solution to avoid distortion of 
voltage-activated currents by inwardly rectifying potassium 
currents. (B) Current to voltage relationship of peak sodium 
currents shown in A. (C) Fraction of cells showing a INa cur-
rent larger than 50 pA for each tested culture condition 
(control: C, pretreatment with TNF-α and IFN-γ for 48 
hours:TI, control cultures treated with dexamethasone: CD, 
cultures co-treated with dexamethasone and TNF-α and 
IFN-γ for 48 hours: TID). The number of cells tested under 
each condition is indicated within the corresponding column. 
(D) Average inward current densities of the cells listed posi-
titve for this current in (C). Note, that d9TI cells show a sim-
ilar percentage of cells with inward currents of similar 
amplitudes as proliferating progenitor cells. The single cell 
showing an inward current under condition d9CD was 
ignored for the analysis of the average current density. The 
sodium current densities were not statistically significantly 
different from each other. Error bars denote mean ± SE.Journal of Neuroinflammation 2008, 5:39 http://www.jneuroinflammation.com/content/5/1/39
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in the relative expression of MBP, CNP and MAG,
cytokine-treated progenitor cells develop less membrane
surface to accommodate myelin proteins during subse-
quent differentiation time in culture. The cytokine-treat-
ment thus seems to arrest the developmental program
inducing the expression of several features of differenti-
ated oligodendrocytes as a set in bipolar surviving cells.
We have previously observed (Figure 3A in [10]) that the
higher percentage of A2B5 positive cells in surviving
cytokine treated cells also corresponds to a larger absolute
number of A2B5 positive cells and can thus not be easily
explained by a preferential survival of immature cells. The
cytokine treatment conditions used in the present study
did not affect the cell density within the first three days in
culture [10]. Hence, the larger percentage of immature
cells surviving after 6 days in differentiation medium
could not be attributed to a lower cell density at the start-
ing point of differentiation. Possible contributions of the
decreasing cell density during the following days on the
arrest of differentiation, caused by a possible reduction of
paracrinely released survival factors other than those sup-
plied in the medium, e.g. endocannabinoids [34] remain
to be investigated in more detail.
Rescue of cytokine-treated cells by corticosteroids
Furthermore, our experiments demonstrate, that coincu-
bation of cytokines with corticosteroids increases the per-
centage of surviving oligodendrocytes, reduces the
percentage of A2B5 positive cells at day 9 to 2% and
restores myelin protein expression and expansion of
membrane surface. In addition the rescued multipolar
cells show a down-regulation of voltage activated Na+-
and delayed K+ current densities characteristic for differen-
tiated oligodendrocytes. Since the absolute values of the
voltage-activated Na+- and outward K+  currents were
increased in the cytokine treated cells compared with con-
trol and dexamethasone treated cells at day 9 in culture
(data not shown) the down-regulation of the current den-
sities in the course of differentiation cannot be attributed
to a simple dilution of preexisting channel proteins in the
increased membrane surface. Taken together this suggests
Figure 5
Outward rectifying currents after three days in proliferation  medium and further six days in differentiation medium Figure 5
Outward rectifying currents after three days in pro-
liferation medium and further six days in differentia-
tion medium. (A) Original current traces in an extracellular 
solution containing 1 mM Ba2+ to eliminate contributions of 
inwardly rectifying K+ currents from cell cultured under con-
dition d3C. (B) Current to voltage relationship of mean cur-
rents shown in (A) measured between 45 and 55 ms 
between the two vertical dashed lines in (A). (C) All cells 
recorded from showed delayed rectifier currents (IKDR) 
(control: C, pretreatment with TNF-α and IFN-γ for 48 
hours:TI, control cultures treated with dexamethasone: CD, 
cultures co-treated with dexamethasone and TNF-α and 
IFN-γ for 48 hours: TID, numbers of cells investigated given 
below bars). Note, that cytokine treatment significantly 
reduced IKDR after 3 days in proliferation medium in accord-
ance with [52]. In contrast to control cells, in which a signifi-
cant down-regulation took place after 6 days in 
differentiation medium (d3C versus d9C), outward K+-cur-
rents in cytokine pretreated biopolar cells showed no further 
down-regulation in differentiation medium (d3TI versus d9TI, 
p > 0.05). A coincubation with dexamethasone however, led 
to a signficant downregulation of IKDR in the surviving 
multipolar cells (d9TI versus d9TID) resulting in a IKDR den-
sity indiscernable from that recorded in cells differentiated 
under control conditions (d9TID versus d9C, p > 0.5). Error 
bars denote mean ± SE. * p < 0.05, ** p < 0.01, *** p < 
0.001).Journal of Neuroinflammation 2008, 5:39 http://www.jneuroinflammation.com/content/5/1/39
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that corticosteroid treatment counteracts the cytokine-
induced inhibition of maturation.
Our cell counts confirm observations of [22], who
showed a protection of more mature oligodendrocytes,
than used in the present investigation, against cytokine-
induced cell death by corticosteroids. Whereas in the
present study dexamethasone, binding to glucocorticoid
(type II) receptors was clearly more potent, aldosterone,
binding like deoxycorticosterone, to mineralocorticoid
(type I) receptors, was similarly effective in this study, sug-
gesting the involvement of both types of glucocorticoid
receptors in the protective mechanism.
Corticosteroid effects on apoptosis, myelin proteins and 
differentiation
Corticosteroids have been reported to promote oli-
godendrocyte maturation in various aspects. Barres et al.
[35] reported, that 1 μM dexamethasone slowed the aver-
age cell-cycle time and allowed differentiation of GC-pos-
itive oligodendrocytes, thus inhibiting progenitor
proliferation (see also [36]). De Vellis and colleagues
[37,38] found, that glycerol phosphate dehydrogenase, an
oligodendrocyte specific enzyme involved in membrane
lipid biosynthesis, is inducible by glucocorticoids. Like-
wise, Poduslo et al. [39] reported that addition of hydro-
cortisone to oligodendroglia in culture increases the level
of mRNA for proteolipid protein, increases the synthesis
of cerebrosides, and activates ketone body metabolizing
enzymes, which serve as precursors for lipid synthesis dur-
ing development. Ved et al. and Byravan and Campagnoni
[40,41] additionally observed an increase in MBP synthe-
sis by hydrocortisone after more than 15 days in mixed
brain cultures from mice. In one study, in contrast, dihy-
drodeoxycorticosterone has been reported to decrease
mRNA levels of MBP, whereas other corticoids did not
cause any effects on the gene expression of this protein
[42]. This could be explained by experiments indicating a
maturation dependent effect of dexamethasone. Thus dex-
amethasone had a stimulatory effect on myelin proteins
which later in culture reversed to an inhibitory effect [43].
In other glial cell types, including glioma and astrocytoma
cell lines [44] as well as in fibroblasts [45] and hepatoma
cells [46] similar anti-apoptotic effects of glucocorticoids
have been noted. However, the antiapoptotic and differ-
entiation promoting effect of dexamethasone is not uni-
versal. In many other cell types, for example thymocytes
and some leukemia cell lines, treatment with glucocorti-
coids induces apoptosis [47], which has led to their com-
mon use as chemotherapeutic agent in lymphomas and
leukemias [48].
Corticosteroid effects on voltage-activated ion currents in 
oligodendrocytes
This is to our knowledge the first investigation of dexam-
ethasone actions on voltage-activated ion currents in oli-
godendrocyte precursor cells. We observed, that two days
of dexamethasone treatment induced no changes of out-
ward K+- and voltage-activated Na+-inward current density
in control or cytokine treated cells. In other cell types,
such as pituitary GH3 cells, dexamethasone has been
shown to cause an enhanced transcription of the Kv1.5
gene as well as effects on the open probability of calcium-
activated BK channels. In T- lymphocytes, in contrast, a
down-regulation of the expression of the Kv1.3 subunits
has been observed [49-51]. The divergent effects on K+-
channels in different cell types correspond to the cell type-
specific effects of corticosteroids on survival and apopto-
sis discussed above, suggesting that cytokines as well as
corticosteroids trigger concerted programmes in specific
cells, the details of which are just starting to be under-
stood.
Corticosteroid effects on K+ inward currents
Earlier investigations on mature oligodendrocytes from
4–6 months old lambs showed decreases in both, K+-
inward as well as outward currents following 48 hrs incu-
bation of 2-week-old cultures with TNF-α [52]. In accord-
ance with these investigations, McLarnon et al. [53] found
diminished mean open times of inwardly rectifying K+
channels in TNF-α preincubated cultured human oli-
godendrocytes. Our finding of inwardly rectifying K+-cur-
Inwardly rectifying K+ currents after three days in proliferation medium and further six days in differentiation medium Figure 6 (see previous page)
Inwardly rectifying K+ currents after three days in proliferation medium and further six days in differentiation 
medium. (A) Original voltage clamp recordings of current traces from cell cultured after 9 days in control solution. No leak 
and capacitance subtraction used to visualize current components at a holding potential of -85 mV. (Aa) Current traces in 
physiological extracellular solution, (Ab) in the same solution containing in addition 1 mM Ba2+. (Ac) plot of the difference 
between traces shown in (Aa) and (Ab) corresponding to the inwardly rectifying K+ current (KIR). (B) Current versus voltage 
relationship for recordings shown in Ac (mean current between the dashed lines in Ac). (C) Fraction of cells showing a KIR cur-
rent larger than 50 pA for each tested culture condition. The number of cells tested under each condition (control: C, pre-
treatment with TNF-α and IFN-γ for 48 hours:TI, control cultures treated with dexamethasone: CD, cultures co-treated with 
dexamethasone and TNF-α and IFN-γ for 48 hours: TID) is indicated within the corresponding column. (D) Average current 
densities of KIR for the cells listed positive for this current in (C). Note, that after 3 days in proliferation medium containing 
TNF-α and IFN-γ for 48 hrs the number of cells showing a KIR was reduced to only 20%. Error bars indicate ± SE.Journal of Neuroinflammation 2008, 5:39 http://www.jneuroinflammation.com/content/5/1/39
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rents of less than 50 pA in 80% of the cells investigated
extends these observations to rat oligodendrocyte precur-
sor cells. This downregulation was only observed in cells
investigated shortly after the cytokine incubation. In cells
investigated 6 days later inward rectifying currents were
almost restored. The cytokine effect may even decline with
a time constant in the range of hours, since in the present
series of experiments inward currents showing current
densities > 50 pA were never observed in the first 20 min-
utes of a recording session. Most interestingly, in cultures
co-treated with dexamethasone the percentage of cells
showing inwardly rectifying K+ currents was restored to
control levels. Leaving K+-outward currents and Na+-
inward currents unaltered dexamethasone selectively pre-
vented the downregulation of the inward K+-current in the
majority of the precursor cells investigated, lending sup-
port to the speculation, that the block of the down-regula-
tion of the inwardly rectifying K+ current could play an
essential part in the protective role of dexamethasone. In
line with the concept, that the reduction of the inwardly
rectifying K+-current plays a causal role in oligodendrocyte
damage, in the lethal Kir4.1 knockout mouse, depolarized
membrane potentials of oligodendrocytes as well as a dis-
turbed myelination with vacuolized white matter are
found [54]. Thus, the following conception emerges:
Cytokine treatment of oligodendrocyte precursor cells
causes a down-regulation of inwardly rectifying potas-
sium currents. The resulting depolarisation could trigger a
concerted programme leading to cell death and possibly
block of differentiation of the surviving cells.
Clinical implications
Corticosteroids are widely used in perinatal medicine to
induce lung maturation. Although our results indicate a
clear protective effect of corticosteroids, especially dexam-
ethasone, on oligodendrocyte precursor cells, studies
examining the effects of corticosteroid treatment on pre-
term infants do not indicate umambiguously protective
effects [55] and in some studies even adverse effects on the
development of PVL [56] have been decribed. Although
the adverse effects of intraveneously administered dexam-
ethasone could have resulted from sulphites in the inject-
able preparation [57], additional deleterious effects of
dexamethasone on brain development [58] and hippoc-
ampal neurons [59] have been reported. Hence it remains
to be investigated, whether other steroids, such as methyl-
prednisolone or betamethasone, which have been shown
to induce less side effects [56], exert a comparable protec-
tive effect on oligodendrocyte precursor cells or whether
other agents interfering with the pathway leading to a
down-regulation of inwardly rectifying K+ currents could
be employed as protectants.
Conclusion
Our results indicate, that cytokine-induced damage to oli-
godendrocyte precursor cells can be prevented at the level
of morphological maturation and the expression of
mature myelin proteins by corticosteroids. Furthermore,
even the physiological function of the damaged cells, as
reflected by the restoration of the differentiated pattern of
the voltage-activated ion currents was rescued. This indi-
cates that cytokine-damaged immature oligodendrocytes
could eventually be functionally restituted by an adequate
pharmacological treatment. Since clinical studies so far
provided less clear results using corticosteroids more
detailed investigations concerning alternative approaches
to interfere with the molecular pathways activated by
cytokines in oligodendrocyte precursor cells have to be
worked out in order to find clinically more successful
agents to protect immature oligodendrocyte precursors.
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